Caricamento...
Clinical Experience and Recent Advances in the Development of Listeria-Based Tumor Immunotherapies
The promise of tumor immunotherapy to significantly improve survival in patients who are refractory to long-standing therapies, such as chemotherapy and radiation, is now being realized. While immune checkpoint inhibitors that target PD-1 and CTLA-4 are leading the charge in clinical efficacy, there...
Salvato in:
| Pubblicato in: | Front Immunol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8081050/ https://ncbi.nlm.nih.gov/pubmed/33936058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.642316 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|